20 May 2022 - Today the FDA approved azacitidine (Vidaza, Celgene) for paediatric patients with newly diagnosed juvenile myelomonocytic leukaemia. ...
21 May 2022 - Top doctors have warned that vulnerable patients who test positive to COVID-19 are missing out on ...
20 May 2022 - Recommendation based on positive results from two clinical trials in which Xenpozyme provided improvement across multiple non-CNS ...
20 May 2022 - European Commission decision anticipated within approximately 60 days. ...
20 May 2022 - Positive opinion could expand the role of Cosentyx (secukinumab) in reducing flare risk in paediatric enthesitis-related arthritis ...
20 May 2022 - Today, the U.S. Food and Drug Administration approved Dupixent (dupilumab) to treat eosinophilic esophagitis in adults and ...
20 May 2022 - Eli Lilly and Incyte announced today that the EMA's CHMP has issued a positive opinion for ...
20 May 2022 - Submission is supported by Phase 3 study that demonstrated patients had significant increases in hours of ...
20 May 2022 - The EMA’s human medicines committee (CHMP) recommended nine medicines for approval at its May 2022 meeting. ...
20 May 2022 - The Department of Health and Social Care has asked NICE to produce guidance on using lumasiran ...
19 May 2022 - Submission follows the U.S. FDA acceptance of the adagrasib new drug application for the same indication ...
20 May 2022 - Medicines Australia has set the scene for major health reform by the next Government by alerting ...
19 May 2022 - Mental health experts say a nasal spray to help relieve depression should be subsidised to make ...
19 May 2022 - Medicines Australia has been assured in official communications from the respective Campaign Headquarters that both the ...
19 May 2022 - The state health insurance review agency said it would broaden the reimbursement criteria for Sprycel (dasatinib), ...